Boston Scientific Corp (XTER:BSX)
€ 87 1.5 (1.75%) Market Cap: 126.63 Bil Enterprise Value: 134.92 Bil PE Ratio: 75.00 PB Ratio: 6.46 GF Score: 79/100

Boston Scientific Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 01:20PM GMT
Release Date Price: €29.24 (-3.72%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good morning, everyone. Happy to move to our next session on the second day of the JPMorgan conference. I'm Robbie Marcus, the medtech analyst here. And we have the Boston Scientific management team. CEO, Mike Mahoney's going to kick it off with a formal presentation, and then we're going to move into Q&A, along with Dr. Ian Meredith and Dan Brennan, the CFO.

So just a few quick housekeeping items. Feel free to go to the JPMorgan health care website and get the slides for the presentation. Feel free to go ahead and put a question there. And then you could also e-mail me or get me on Bloomberg chat. And I can do my best to ask your questions.

So with that, go ahead. And I will join you for Q&A.

Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO

Thank you very much, Robbie. We appreciate the opportunity, and thanks again for all of your interest.

2020 certainly offers challenges, but I'm very proud of how the BSC team

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot